NTRK2 and cancer: Intriguingly, the ability of GBMs to make less invasive cancer cells around them more aggressive appears to be linked to the transfer of TrkB-containing exosomes, revealing a mechanism by which GBM tumors can influence their environment to promote disease progression and aggressiveness [289].